Avenue Therapeutics, Inc.

Historical 13F Holders

Symbol
ATXI
CUSIP
05360L403
All holders as of
Q4 2024
Type
Equity
Class
COM NEW
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for 05360L403 since 12/18/2024, newest first.

Filer % of Class Filed
Ikarian Capital, LLC 13G/A Amendment 1
4.1% 2/17/2026
Event 12/31/2025
Fortress Biotech, Inc. 13D/A Amendment 8 13.4% 1/6/2026
Event 1/2/2026
Fortress Biotech, Inc. 13D/A Amendment 7 10.3% 4/2/2025
Event 3/31/2025
Armistice Capital, LLC 13G/A Amendment 1
4.99% 2/14/2025
Event 12/31/2024
Ikarian Capital, LLC 13G
6.8% 2/14/2025
Event 12/31/2024
Fortress Biotech, Inc. 13D/A Amendment 6 13.8% 1/3/2025
Event 12/31/2024

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2024 Q4 8 193 k $385 k
2024 Q3 10 198 k $492 k
2024 Q2 11 116 k $407 k